Reykjavik, Iceland – October 13, 2026 – Kerecis, the company pioneering the use of sustainably sourced fish skin for tissue regeneration and part of Coloplast Wound & Tissue Repair, today announced the commercial launch of its fish-skin technology in Canada following Health Canada approval. Supported by Coloplast’s long-standing presence and reputation in the Canadian market, the launch expands access to a new regenerative treatment option for burns, traumatic injuries, surgical wounds, diabetic foot ulcers, and other complex and hard-to-heal wounds.
The launch brings to Canada a technology with roots in the fishing communities of northwest Iceland, where Kerecis was founded on a simple idea: that cod skin, traditionally discarded during fish processing, could be transformed into a medical device capable of supporting the body’s natural ability to regenerate tissue. From its origins in Isafjordur, Kerecis has built a global business around the belief that responsible use of natural resources can lead to meaningful medical innovation. Today Kerecis technology is used in hospitals and clinics across North America, Europe, Australia, and other international markets.
Kerecis fish-skin grafts preserve the natural structure and composition of the skin, supporting cellular ingrowth and tissue regeneration.
The launch also reflects growing interest in healthcare technologies that make smarter use of natural resources. Kerecis products are manufactured from sustainably sourced North Atlantic cod skin that would otherwise go unused, creating value from a resource stream that has historically generated little economic return after food production.
Canada represents the latest step in Kerecis’ international expansion and provides healthcare professionals with access to a new category of regenerative technology at a time when treatment options remain limited for many patients requiring advanced tissue repair
From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory clearance in the United States, Canada, Europe, and beyond.
